Financing vaccines in the 21st century: assuring access and availability
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
c2004
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002 Includes bibliographical references (p. 211-220) Introduction -- Background -- Conceptual framework for the study -- Study process -- Summing up -- Organization of the report -- Origins and rationale of immunization policy -- Legislative history of vaccine policy -- Shared federal and state responsibility for financing -- Shared public and private responsibility for coverage -- Public and private delivery systems -- Private vaccine production -- The setting national of vaccine policy -- Findings -- Public and private insurance coverage -- Public insurance coverage -- Private insurance coverage -- Barriers to a well-functioning immunization finance system -- Findings -- The delivery system -- Delivery of adult and childhood vaccines -- The work of immunizing -- Provider reimbursement -- Barriers to a well-functioning immunization delivery system -- Findings -- Vaccine supply -- Size and growth of the vaccine market -- Vaccine production -- Cost structure -- Research and development -- Industry concentration -- Regulation -- Pricing -- Shortages -- Stockpiles -- CDC contracting -- Barriers to a well-functioning vaccine supply system -- Findings -- Conclusions and alternative strategies -- Conclusions -- Alternative strategies -- Weighing the alternatives -- Recommendations -- Final observations |
| Beschreibung: | 1 Online-Ressource (xiii, 247 p.) |
| ISBN: | 0309526191 9780309526197 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043096774 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2004 |||| o||u| ||||||eng d | ||
| 020 | |a 0309526191 |c PDF |9 0-309-52619-1 | ||
| 020 | |a 9780309526197 |c PDF |9 978-0-309-52619-7 | ||
| 035 | |a (OCoLC)61460423 | ||
| 035 | |a (DE-599)BVBBV043096774 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 614.4/7 |2 22 | |
| 245 | 1 | 0 | |a Financing vaccines in the 21st century |b assuring access and availability |c Committee on the Evaluation of Vaccine Purchase Financing in the United States, Board on Health Care Services, Institute of Medicine |
| 246 | 1 | 3 | |a Financing vaccines in the twenty-first century |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c c2004 | |
| 300 | |a 1 Online-Ressource (xiii, 247 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002 | ||
| 500 | |a Includes bibliographical references (p. 211-220) | ||
| 500 | |a Introduction -- Background -- Conceptual framework for the study -- Study process -- Summing up -- Organization of the report -- Origins and rationale of immunization policy -- Legislative history of vaccine policy -- Shared federal and state responsibility for financing -- Shared public and private responsibility for coverage -- Public and private delivery systems -- Private vaccine production -- The setting national of vaccine policy -- Findings -- Public and private insurance coverage -- Public insurance coverage -- Private insurance coverage -- Barriers to a well-functioning immunization finance system -- Findings -- The delivery system -- Delivery of adult and childhood vaccines -- The work of immunizing -- Provider reimbursement -- Barriers to a well-functioning immunization delivery system -- Findings -- Vaccine supply -- Size and growth of the vaccine market -- Vaccine production -- Cost structure -- Research and development -- Industry concentration -- Regulation -- Pricing -- Shortages -- Stockpiles -- CDC contracting -- Barriers to a well-functioning vaccine supply system -- Findings -- Conclusions and alternative strategies -- Conclusions -- Alternative strategies -- Weighing the alternatives -- Recommendations -- Final observations | ||
| 650 | 7 | |a MEDICAL / Health Risk Assessment |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Epidemiology |2 bisacsh | |
| 650 | 4 | |a Vaccination / États-Unis / Planification | |
| 650 | 4 | |a Vaccins / Aspect économique / États-Unis | |
| 650 | 4 | |a Vaccination / Aspect économique / États-Unis | |
| 650 | 4 | |a Vaccination / Politique gouvernementale / États-Unis | |
| 650 | 4 | |a Mass Immunization / economics / United States | |
| 650 | 4 | |a Vaccines / economics / United States | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Politik | |
| 650 | 4 | |a Vaccination |z United States |x Planning | |
| 650 | 4 | |a Vaccines |x Economic aspects |z United States | |
| 650 | 4 | |a Vaccination |x Economic aspects |z United States | |
| 650 | 4 | |a Vaccination |x Government policy |z United States | |
| 651 | 4 | |a USA | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Committee on the Evaluation of Vaccine Purchase Financing in the United States |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 0-309-08979-4 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 978-0-309-08979-1 |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=104500 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028520966 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=104500 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=104500 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175502724825088 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043096774 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)61460423 (DE-599)BVBBV043096774 |
| dewey-full | 614.4/7 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 614 - Forensic medicine; incidence of disease |
| dewey-raw | 614.4/7 |
| dewey-search | 614.4/7 |
| dewey-sort | 3614.4 17 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04096nmm a2200577zc 4500</leader><controlfield tag="001">BV043096774</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2004 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309526191</subfield><subfield code="c">PDF</subfield><subfield code="9">0-309-52619-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309526197</subfield><subfield code="c">PDF</subfield><subfield code="9">978-0-309-52619-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)61460423</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043096774</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">614.4/7</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Financing vaccines in the 21st century</subfield><subfield code="b">assuring access and availability</subfield><subfield code="c">Committee on the Evaluation of Vaccine Purchase Financing in the United States, Board on Health Care Services, Institute of Medicine</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Financing vaccines in the twenty-first century</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiii, 247 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 211-220)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- Background -- Conceptual framework for the study -- Study process -- Summing up -- Organization of the report -- Origins and rationale of immunization policy -- Legislative history of vaccine policy -- Shared federal and state responsibility for financing -- Shared public and private responsibility for coverage -- Public and private delivery systems -- Private vaccine production -- The setting national of vaccine policy -- Findings -- Public and private insurance coverage -- Public insurance coverage -- Private insurance coverage -- Barriers to a well-functioning immunization finance system -- Findings -- The delivery system -- Delivery of adult and childhood vaccines -- The work of immunizing -- Provider reimbursement -- Barriers to a well-functioning immunization delivery system -- Findings -- Vaccine supply -- Size and growth of the vaccine market -- Vaccine production -- Cost structure -- Research and development -- Industry concentration -- Regulation -- Pricing -- Shortages -- Stockpiles -- CDC contracting -- Barriers to a well-functioning vaccine supply system -- Findings -- Conclusions and alternative strategies -- Conclusions -- Alternative strategies -- Weighing the alternatives -- Recommendations -- Final observations</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Health Risk Assessment</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Epidemiology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccination / États-Unis / Planification</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccins / Aspect économique / États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccination / Aspect économique / États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccination / Politique gouvernementale / États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mass Immunization / economics / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines / economics / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccination</subfield><subfield code="z">United States</subfield><subfield code="x">Planning</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccination</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccination</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Committee on the Evaluation of Vaccine Purchase Financing in the United States</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">0-309-08979-4</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">978-0-309-08979-1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=104500</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028520966</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=104500</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=104500</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043096774 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:17:19Z |
| institution | BVB |
| isbn | 0309526191 9780309526197 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028520966 |
| oclc_num | 61460423 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xiii, 247 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Financing vaccines in the 21st century assuring access and availability Committee on the Evaluation of Vaccine Purchase Financing in the United States, Board on Health Care Services, Institute of Medicine Financing vaccines in the twenty-first century Washington, D.C. National Academies Press c2004 1 Online-Ressource (xiii, 247 p.) txt rdacontent c rdamedia cr rdacarrier Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002 Includes bibliographical references (p. 211-220) Introduction -- Background -- Conceptual framework for the study -- Study process -- Summing up -- Organization of the report -- Origins and rationale of immunization policy -- Legislative history of vaccine policy -- Shared federal and state responsibility for financing -- Shared public and private responsibility for coverage -- Public and private delivery systems -- Private vaccine production -- The setting national of vaccine policy -- Findings -- Public and private insurance coverage -- Public insurance coverage -- Private insurance coverage -- Barriers to a well-functioning immunization finance system -- Findings -- The delivery system -- Delivery of adult and childhood vaccines -- The work of immunizing -- Provider reimbursement -- Barriers to a well-functioning immunization delivery system -- Findings -- Vaccine supply -- Size and growth of the vaccine market -- Vaccine production -- Cost structure -- Research and development -- Industry concentration -- Regulation -- Pricing -- Shortages -- Stockpiles -- CDC contracting -- Barriers to a well-functioning vaccine supply system -- Findings -- Conclusions and alternative strategies -- Conclusions -- Alternative strategies -- Weighing the alternatives -- Recommendations -- Final observations MEDICAL / Health Risk Assessment bisacsh MEDICAL / Epidemiology bisacsh Vaccination / États-Unis / Planification Vaccins / Aspect économique / États-Unis Vaccination / Aspect économique / États-Unis Vaccination / Politique gouvernementale / États-Unis Mass Immunization / economics / United States Vaccines / economics / United States Medizin Politik Vaccination United States Planning Vaccines Economic aspects United States Vaccination Economic aspects United States Vaccination Government policy United States USA Institute of Medicine (U.S.) Committee on the Evaluation of Vaccine Purchase Financing in the United States Sonstige oth Erscheint auch als Druck-Ausgabe, Paperback 0-309-08979-4 Erscheint auch als Druck-Ausgabe, Paperback 978-0-309-08979-1 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=104500 Aggregator Volltext |
| spellingShingle | Financing vaccines in the 21st century assuring access and availability MEDICAL / Health Risk Assessment bisacsh MEDICAL / Epidemiology bisacsh Vaccination / États-Unis / Planification Vaccins / Aspect économique / États-Unis Vaccination / Aspect économique / États-Unis Vaccination / Politique gouvernementale / États-Unis Mass Immunization / economics / United States Vaccines / economics / United States Medizin Politik Vaccination United States Planning Vaccines Economic aspects United States Vaccination Economic aspects United States Vaccination Government policy United States |
| title | Financing vaccines in the 21st century assuring access and availability |
| title_alt | Financing vaccines in the twenty-first century |
| title_auth | Financing vaccines in the 21st century assuring access and availability |
| title_exact_search | Financing vaccines in the 21st century assuring access and availability |
| title_full | Financing vaccines in the 21st century assuring access and availability Committee on the Evaluation of Vaccine Purchase Financing in the United States, Board on Health Care Services, Institute of Medicine |
| title_fullStr | Financing vaccines in the 21st century assuring access and availability Committee on the Evaluation of Vaccine Purchase Financing in the United States, Board on Health Care Services, Institute of Medicine |
| title_full_unstemmed | Financing vaccines in the 21st century assuring access and availability Committee on the Evaluation of Vaccine Purchase Financing in the United States, Board on Health Care Services, Institute of Medicine |
| title_short | Financing vaccines in the 21st century |
| title_sort | financing vaccines in the 21st century assuring access and availability |
| title_sub | assuring access and availability |
| topic | MEDICAL / Health Risk Assessment bisacsh MEDICAL / Epidemiology bisacsh Vaccination / États-Unis / Planification Vaccins / Aspect économique / États-Unis Vaccination / Aspect économique / États-Unis Vaccination / Politique gouvernementale / États-Unis Mass Immunization / economics / United States Vaccines / economics / United States Medizin Politik Vaccination United States Planning Vaccines Economic aspects United States Vaccination Economic aspects United States Vaccination Government policy United States |
| topic_facet | MEDICAL / Health Risk Assessment MEDICAL / Epidemiology Vaccination / États-Unis / Planification Vaccins / Aspect économique / États-Unis Vaccination / Aspect économique / États-Unis Vaccination / Politique gouvernementale / États-Unis Mass Immunization / economics / United States Vaccines / economics / United States Medizin Politik Vaccination United States Planning Vaccines Economic aspects United States Vaccination Economic aspects United States Vaccination Government policy United States USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=104500 |
| work_keys_str_mv | AT instituteofmedicineuscommitteeontheevaluationofvaccinepurchasefinancingintheunitedstates financingvaccinesinthe21stcenturyassuringaccessandavailability AT instituteofmedicineuscommitteeontheevaluationofvaccinepurchasefinancingintheunitedstates financingvaccinesinthetwentyfirstcentury |